LBI-0942

THERAPEUTIC AREA

SOLID TUMOR CANCER

LBI-0942

Indications:
Breast, Lung, Pancreas Cancer
REGULATORY PATHWAY

Generic ANDA

TARGET INDICATION

Contract development funds company and builds out commercial manufacturing process for Luminus Nano medicines

CURRENT DEVELOPMENT STATUS

Active CMC development in process

CURRENT DEVELOPMENT STATUS

Clinical studies

TIME TO HUMAN BENEFIT

Bioequivalence study to begin in the 1st quarter of 2020

IMMEDIATE FUNDING REQUIRED?

No, fully funded by partner